Autoantibodies in moderate and critical cases of COVID-19.
作者信息
Chang Soon Hee, Minn Dohsik, Kim Yu Kyung
机构信息
Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu, Korea.
Department of Diagnostic Immunology, Seegene Medical Foundation, Seoul, Korea.
出版信息
Clin Transl Sci. 2021 Sep;14(5):1625-1626. doi: 10.1111/cts.13036. Epub 2021 May 2.
Abstract
摘要
相似文献
1
Autoantibodies in moderate and critical cases of COVID-19.新冠病毒肺炎中重度和危重症病例中的自身抗体。
Clin Transl Sci. 2021 Sep;14(5):1625-1626. doi: 10.1111/cts.13036. Epub 2021 May 2.
2
Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection.新冠病毒感染后6个月内肾移植受者体内抗新冠病毒抗体的下降与丧失
Kidney Int. 2021 Feb;99(2):486-488. doi: 10.1016/j.kint.2020.12.001.
3
[Use of the SARS-CoV-2 antigen detection test in nasopharyngeal swab for COVID-19 infection control].[严重急性呼吸综合征冠状病毒2抗原检测试验在鼻咽拭子中用于2019冠状病毒病感染防控的应用]
Rev Esp Quimioter. 2020 Dec;33(6):390-391. doi: 10.37201/req/127.2020. Epub 2020 Nov 24.
4
Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients.血清学检测抗 SARS-CoV-2 抗体可提高 COVID-19 患者诊断的灵敏度。
Med Microbiol Immunol. 2021 Dec;210(5-6):283-289. doi: 10.1007/s00430-021-00721-6. Epub 2021 Sep 25.
5
Unified platform for genetic and serological detection of COVID-19 with single-molecule technology.基于单分子技术的新冠病毒基因和血清学联合检测通用平台。
PLoS One. 2021 Jul 26;16(7):e0255096. doi: 10.1371/journal.pone.0255096. eCollection 2021.
6
Granuloma annulare triggered by SARS-CoV-2 infection. The first reported case.由新型冠状病毒感染引发的环状肉芽肿。首例报告病例。
J Dermatol. 2021 Jan;48(1):e1-e2. doi: 10.1111/1346-8138.15594. Epub 2020 Nov 9.
7
Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019.COVID-19 严重程度导致的细胞因子产生的早期差异。
J Infect Dis. 2021 Apr 8;223(7):1145-1149. doi: 10.1093/infdis/jiab005.
8
Serological evaluation of patients with coronavirus disease-2019 in Daegu, South Korea.韩国大邱市 2019 年冠状病毒病患者的血清学评估。
PLoS One. 2022 Jan 20;17(1):e0262820. doi: 10.1371/journal.pone.0262820. eCollection 2022.
9
Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.比较两种全自动检测 COVID-19 核衣壳 N 蛋白和刺突 S1/S2 蛋白抗体的检测方法。
Diagn Microbiol Infect Dis. 2021 Jan;99(1):115197. doi: 10.1016/j.diagmicrobio.2020.115197. Epub 2020 Aug 29.
10
Development and evaluation of a serological test for diagnosis of COVID-19 with selected recombinant spike proteins.开发和评估一种基于选定的重组刺突蛋白的血清学检测方法，用于 COVID-19 的诊断。
Eur J Clin Microbiol Infect Dis. 2021 May;40(5):921-928. doi: 10.1007/s10096-020-04102-4. Epub 2020 Nov 12.
引用本文的文献
1
Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review.长新冠的定义、症状、风险因素、流行病学及自身免疫：一篇叙述性综述
Am J Med Open. 2024 Feb 14;11:100068. doi: 10.1016/j.ajmo.2024.100068. eCollection 2024 Jun.
2
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study.抗核抗体（ANA）的出现作为COVID-19患者死亡和发病的潜在危险因素：一项单中心回顾性研究。
Biomedicines. 2024 Jun 13;12(6):1306. doi: 10.3390/biomedicines12061306.
3
Antinuclear Antibody Positivity in Patients With Hair Loss After COVID-19 Infection.新冠病毒感染后脱发患者的抗核抗体阳性
Dermatol Pract Concept. 2023 Apr 1;13(2). doi: 10.5826/dpc.1302a81.
4
Clinical significance of antinuclear antibody positivity in patients with severe coronavirus disease 2019.抗核抗体阳性在重症 2019 冠状病毒病患者中的临床意义。
Korean J Intern Med. 2023 May;38(3):417-426. doi: 10.3904/kjim.2022.352. Epub 2023 Apr 6.
5
Detection of Antinuclear Antibodies Targeting Intracellular Signal Transduction, Metabolism, Apoptotic Processes and Cell Death in Critical COVID-19 Patients.重症新型冠状病毒肺炎患者中靶向细胞内信号转导、代谢、凋亡过程及细胞死亡的抗核抗体检测
Mediterr J Hematol Infect Dis. 2022 Nov 1;14(1):e2022076. doi: 10.4084/MJHID.2022.076. eCollection 2022.
6
Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.分子模拟、免疫系统亢进和 SARS-CoV-2 是 COVID-19 感染后引发自身免疫性疾病三角的三个前提条件。
Int Immunopharmacol. 2022 Nov;112:109183. doi: 10.1016/j.intimp.2022.109183. Epub 2022 Aug 22.
7
Immunological evaluation of patients with 2019 novel coronavirus pneumonia: CD4+ and CD16+ cells may predict severity and prognosis.新型冠状病毒肺炎患者的免疫学评估：CD4+和 CD16+细胞可能预测疾病严重程度和预后。
PLoS One. 2022 Aug 5;17(8):e0268712. doi: 10.1371/journal.pone.0268712. eCollection 2022.
8
Clinical Phenotypes and Mortality Biomarkers: A Study Focused on COVID-19 Patients with Neurological Diseases in Intensive Care Units.临床表型与死亡生物标志物：一项针对重症监护病房中患有神经疾病的新冠肺炎患者的研究
Behav Sci (Basel). 2022 Jul 15;12(7):234. doi: 10.3390/bs12070234.
9
Assessment of background levels of autoantibodies as a prognostic marker for severe SARS-CoV-2 infection.评估自身抗体背景水平作为严重新型冠状病毒 2 型感染的预后标志物。
J Circ Biomark. 2022 May 3;11:24-27. doi: 10.33393/jcb.2022.2337. eCollection 2022 Jan-Dec.
10
Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures.COVID-19 中的自身抗体与抗病毒体液反应和独特的免疫特征相关。
Allergy. 2022 Aug;77(8):2415-2430. doi: 10.1111/all.15302. Epub 2022 Apr 8.
本文引用的文献
1
SARS-CoV-2 infection as a trigger of autoimmune response.新型冠状病毒2型感染作为自身免疫反应的触发因素。
Clin Transl Sci. 2021 May;14(3):898-907. doi: 10.1111/cts.12953. Epub 2021 Jan 21.
2
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful?COVID-19 与免疫失调：自身抗体是否有用？
Clin Transl Sci. 2021 Mar;14(2):502-508. doi: 10.1111/cts.12908. Epub 2021 Jan 20.
3
The correlation between SARS-CoV-2 infection and rheumatic disease.新型冠状病毒2019感染与风湿性疾病之间的相关性。
Autoimmun Rev. 2020 Jul;19(7):102557. doi: 10.1016/j.autrev.2020.102557. Epub 2020 May 1.
4
Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19.COVID-19 重型和危重型病例的临床和自身免疫特征。
Clin Transl Sci. 2020 Nov;13(6):1077-1086. doi: 10.1111/cts.12805. Epub 2020 May 14.
5
A Brief Telephone Severity Scoring System and Therapeutic Living Centers Solved Acute Hospital-Bed Shortage during the COVID-19 Outbreak in Daegu, Korea.韩国大邱市在 COVID-19 疫情期间使用简短电话严重度评分系统和治疗性生活中心缓解急性医院床位短缺
J Korean Med Sci. 2020 Apr 20;35(15):e152. doi: 10.3346/jkms.2020.35.e152.
Zotero 插件